Amedeo Smart

Free Medical Literature Service


 

Amedeo

Malignant Lymphoma

  Free Subscription

Articles published in
Cancer Lett
    January 2024
  1. WANG WT, Xing TY, Du KX, Hua W, et al
    CD30 protects EBV-positive diffuse large B-cell lymphoma cells against mitochondrial dysfunction through BNIP3-mediated mitophagy.
    Cancer Lett. 2024 Jan 9:216616. doi: 10.1016/j.canlet.2024.216616.
    >> Share

    October 2022
  2. DU Y, Cai Y, Lv Y, Zhang L, et al
    Single-cell RNA sequencing unveils the communications between malignant T and myeloid cells contributing to tumor growth and immunosuppression in cutaneous T-cell lymphoma.
    Cancer Lett. 2022 Oct 17:215972. doi: 10.1016/j.canlet.2022.215972.
    >> Share

    June 2022
  3. WANG K, Wei J, Ma J, Jia Q, et al
    Phosphorylation of PBK/TOPK Tyr74 by JAK2 promotes Burkitt lymphoma tumor growth.
    Cancer Lett. 2022;544:215812.
    >> Share

    April 2022
  4. SUN Q, Ye Y, Gui A, Sun X, et al
    MORTALIN-Ca(2+) axis drives innate rituximab resistance in diffuse large B-cell lymphoma.
    Cancer Lett. 2022 Apr 18:215678. doi: 10.1016/j.canlet.2022.215678.
    >> Share

    January 2022
  5. XING Y, Guo W, Wu M, Xie J, et al
    An orally available small molecule BCL6 inhibitor effectively suppresses diffuse large B cell lymphoma cells growth in vitro and in vivo.
    Cancer Lett. 2022 Jan 3. pii: S0304-3835(21)00658.
    >> Share

    December 2021
  6. DANG W, Cao P, Yan Q, Yang L, et al
    IGFBP7-AS1 is a p53-responsive long noncoding RNA downregulated by Epstein-Barr virus that contributes to viral tumorigenesis.
    Cancer Lett. 2021;523:135-147.
    >> Share

    October 2021
  7. CHEN ZQ, Cao ZR, Wang Y, Zhang X, et al
    Repressing MYC by targeting BET synergizes with selective inhibition of PI3Kalpha against B cell lymphoma.
    Cancer Lett. 2021;524:206-218.
    >> Share

  8. COX MC, Bocci G
    Metronomic chemotherapy regimens and targeted therapies in non-Hodgkin lymphoma: The best of two worlds.
    Cancer Lett. 2021;524:144-150.
    >> Share

    September 2021
  9. SUN Y, Gao Y, Chen J, Huang L, et al
    CREBBP cooperates with the cell cycle machinery to attenuate chidamide sensitivity in relapsed/refractory diffuse large B-cell lymphoma.
    Cancer Lett. 2021 Sep 2. pii: S0304-3835(21)00438.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016